Search company, investor...
Komodo Health company logo

Komodo Health

Founded Year



Unattributed | Alive

Total Raised


Last Raised

$200M | 7 mos ago

About Komodo Health

Komodo Health operates a healthcare insights platform. It brings transparency and market intelligence to healthcare and life sciences. It uses tools and brings together data across enterprises, the public domain, and proprietary sources, enabling healthcare and life science industries. The company was founded in 2014 and is based in San Francisco, California.

Headquarters Location

680 Folsom Street Suite 500

San Francisco, California, 94107,

United States

Missing: Komodo Health's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

ESPs containing Komodo Health

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare & Life Sciences / Health Data & Analytics

The healthcare data science platforms market offers a range of solutions that enable healthcare organizations to harness the power of AI and machine learning to improve patient outcomes, increase access to care, and optimize revenue cycle workflows. These platforms consolidate data from various sources, clean and enhance it for use across different scenarios, and ultimately enable unified patient …

Komodo Health named as Leader among 15 other companies, including Innovaccer, Health Gorilla, and ArborMetrix.

Missing: Komodo Health's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Komodo Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Komodo Health in 5 CB Insights research briefs, most recently on Jan 24, 2023.

Expert Collections containing Komodo Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Komodo Health is included in 8 Expert Collections, including Unicorns- Billion Dollar Startups.


Unicorns- Billion Dollar Startups

1,215 items


Conference Exhibitors

5,302 items


Digital Health 150

300 items

The winners of the second annual CB Insights Digital Health 150.


Digital Health

10,347 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


Health IT

2,816 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.


Digital Hospital

200 items

Komodo Health Patents

Komodo Health has filed 2 patents.

The 3 most popular patent topics include:

  • Cardinal numbers
  • Data modeling
  • Graph data structures
patents chart

Application Date

Grant Date


Related Topics



Cardinal numbers, Set theory, Data modeling, Infinity, Networks


Application Date


Grant Date


Related Topics

Cardinal numbers, Set theory, Data modeling, Infinity, Networks



Latest Komodo Health News

Particle Health Appoints Jason Prestinario as CEO

May 16, 2023

May 15, 2023 Jason Prestinario NEW YORK–( BUSINESS WIRE )– Particle Health , an interoperability platform that aggregates and delivers actionable patient data and insights to healthcare companies, today announced that it has appointed  Jason Prestinario as the company’s next CEO, effective May 15, 2023. Troy Bannister, founder and current CEO, will continue with Particle as Chief Strategy Officer, where he will spearhead product innovation. “Our board is pleased to introduce Jason Prestinario as Particle Health’s next CEO,” said Greg Yap, Partner at Menlo Ventures. “Jason’s impressive track record of driving business growth and technical innovation makes him an excellent choice to lead Particle’s next stage. His strategic focus, operational effectiveness, and technological expertise will help expand the reach and clinical impact of the Particle platform. We also look forward to Troy Bannister’s continued leadership at Particle – his vision, passion, and dedication has helped make Particle an innovative leader in improving healthcare data interoperability.” Jason joins Particle from Komodo Health, where he served as the general manager of the company’s Healthcare Solutions Business Unit and led the expansion of its data platform to reach the wider healthcare ecosystem including payers and providers. As an engineer-turned-operator, he started at Komodo as Head of Data Science and was appointed to product engineering leadership positions where he was instrumental in building and launching Prism and Sentinel, two of Komodo’s most dominant products. Prior to his time at Komodo, Jason was at Palantir Technologies. He holds a Bachelor of Science and Master of Science in Mechanical Engineering from Stanford University. “Particle Health has revolutionized how healthcare data is accessed and exchanged,” shared Jason. “As someone who is deeply passionate about driving better patient outcomes, I found my calling scaling healthcare data companies. I’m excited to join Particle during this period of rapid growth and eager to push us further and faster. By extending the reach of Particle’s industry-leading bidirectional data exchange and removing the friction in sharing critical health data, Particle will unlock a healthier future.” Particle’s mission is evolving from enabling simple and secure access to actionable healthcare data to that of building a category-leading platform that allows their customers to integrate and analyze their data to solve their most urgent problems. Particle’s Platform curates a comprehensive, transparent and longitudinal patient profile that helps serve a multitude of markets and use cases, all with the intention of positively impacting patient outcomes. Impactful use cases include onboarding new patients to ensure proper care journeys, reducing duplicative testing and procedures to decrease cost of care, and improving patient outcomes by preventing comorbidities and disease progression by helping clinicians address issues early and seamlessly. “I’m really proud of how much Particle has accomplished over the last five years as we’ve executed on our mission to dramatically improve lives by enabling secure access to vital medical data,” said Troy. “As we transition to the next phase of growth, the Board and I believe that Jason, with his significant data science and healthcare leadership background, is well positioned to steer the organization throughout this process. I welcome him to the team and look forward to working together.” About Particle Health Founded in 2018, Particle Health has built the integrations and APIs that enable a modern, seamless data experience for healthcare companies. We create intuitive experiences for developers, build scalable infrastructure product teams love, drive valuable insights for clinicians, and collaborate with innovative leaders launching data-driven healthcare solutions. Learn more about Particle at:

Komodo Health Frequently Asked Questions (FAQ)

  • When was Komodo Health founded?

    Komodo Health was founded in 2014.

  • Where is Komodo Health's headquarters?

    Komodo Health's headquarters is located at 680 Folsom Street, San Francisco.

  • What is Komodo Health's latest funding round?

    Komodo Health's latest funding round is Unattributed.

  • How much did Komodo Health raise?

    Komodo Health raised a total of $515M.

  • Who are the investors of Komodo Health?

    Investors of Komodo Health include Dragoneer Investment Group, Coatue Management, Andreessen Horowitz, SVB Capital, ICONIQ Growth and 9 more.

  • Who are Komodo Health's competitors?

    Competitors of Komodo Health include Kythera Labs, Holmusk, Amalgam Rx, QantEv, PurpleLab and 8 more.

Compare Komodo Health to Competitors

Clarify Health Logo
Clarify Health

Clarify Health collects records of rendered healthcare in the United States for the purpose of providing more granular and precise analytics to healthcare organizations, spanning from providers to payers and life sciences. Clarify's software solutions are fueled by a patient-level data set and incorporate clinical, claim, prescription, lab and socio-behavioral determinants of health data. Its analytics platform is powered by a technology stack inspired by those used in banking and logistics and provides doctors and insurers greater visibility into cost, quality, referrals, utilization, and member risk. The company is also helping life sciences organizations analyze and integrate rich data to determine the optimal sites and designs for clinical trials as well as accelerate clinical development timelines. The company was founded in 2015 and is based in San Francisco, California.

Promptly Health

Promptly Health is a patient empowerment focused healthcare app that helps individuals understand how they will fee after treatment, medication, or surgery.

ConcertAI Logo

ConcertAI specializes in integrated clinical RWD, AI solutions and outcomes science with a large RWD oncology dataset. ConcertAI develops a medical research tool suite that offers care-based oncology research and data analytics.

Evidation Logo

Evidation operates as a multichannel health tracking platform. It enables users to connect with multiple appications to track everyday activity and earn rewards for steps, sleep, surveys, and more. The company was founded in 2012 and is based in San Mateo, California.

Aetion Logo

Aetion is a healthcare analytics company. It provides decision-grade real-world evidence solutions to biopharma companies, payers, and regulatory agencies. It offers a platform that analyzes data from the real world to produce scientifically validated answers on treatments, effectiveness, and value. The company was founded in 2012 and is based in New York, New York.


Verantos provides high-validity real-world evidence for life sciences. By incorporating robust clinical narrative data, AI technology, and measured validity, Verantos generates research-grade evidence at scale across all therapeutic areas. The Verantos Evidence Platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for market access, HEOR, medical affairs, and regulatory use. The company was founded in 2015 and is based in Menlo Park, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.